Danaher Co. (NYSE:DHR) Shares Sold by Midland Wealth Advisors LLC

Midland Wealth Advisors LLC lowered its stake in shares of Danaher Co. (NYSE:DHR) by 10.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 3,004 shares of the conglomerate’s stock after selling 341 shares during the quarter. Midland Wealth Advisors LLC’s holdings in Danaher were worth $690,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Kentucky Retirement Systems Insurance Trust Fund increased its stake in Danaher by 11.6% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate’s stock valued at $4,874,000 after purchasing an additional 2,202 shares in the last quarter. ORG Partners LLC grew its holdings in shares of Danaher by 1,212.8% during the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock valued at $636,000 after buying an additional 2,559 shares during the last quarter. Generate Investment Management Ltd acquired a new position in shares of Danaher in the 4th quarter valued at $8,044,000. Stifel Financial Corp raised its stake in Danaher by 1.3% in the 3rd quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock worth $235,583,000 after acquiring an additional 11,216 shares during the last quarter. Finally, Compass Capital Management Inc. grew its stake in Danaher by 4.8% during the 4th quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate’s stock valued at $54,615,000 after purchasing an additional 10,994 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Price Performance

Danaher stock opened at $212.35 on Monday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The company’s fifty day moving average price is $222.51 and its 200 day moving average price is $242.62. The stock has a market capitalization of $151.77 billion, a P/E ratio of 40.22, a P/E/G ratio of 2.66 and a beta of 0.82. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the company earned $2.09 earnings per share. As a group, equities research analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.60%. The ex-dividend date of this dividend is Friday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is 24.24%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a research note on Friday, December 13th. Guggenheim assumed coverage on shares of Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective for the company. Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 price objective (down previously from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Raymond James reissued a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Finally, StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.